Cardiolinc partner Firalis S.A. and Celemics, Inc. announce the commercialization of a long non-coding RNA (lncRNA) panel, FiMICS®. The identification of the 3233 cardiac-enriched lncRNAs in blood samples included in the panel was achieved in collaboration with members of Cardiolinc.
The Cardiolinc Annual Meeting 2018 was held in Munich during the European Society of Cardiology Congress on August 28, 2018.
The University Medical Center Utrecht and Utrecht University are looking for PhD candidates for the H2020 Marie S. Curie program called RESCUE.
Cardiolinc members and partners are invited to join the Annual Meeting and General Assembly in Munich on August 28.
The COST Action proposed by Cardiolinc Board Members Yvan Devaux and Clarissa Pedrosa da C. Gomes and co-proposed by other Cardiolinc members, partners and external collaborators has been approved.
With the registration of Cardiolinc as a non-profit organization last November, the network restructured some of its processes, including the membership and partnership rules and procedures, and will implement these changes from now on.
Heart disease is the main killer worldwide. It kills more women than men as they are often underdiagnosed, undertreated, and suffer more adverse effects to treatments.